tiprankstipranks

Frank Palantoni Insider Profile

4 Followers
Frank Palantoni, Director at Lexicon Pharmaceuticals, holds 40.33K shares in Lexicon Pharmaceuticals (Ticker: LXRX), holds 32.38K shares in Prestige Consumer Healthcare (Ticker: PBH), holds 57.07K shares in Central Garden Pet (Ticker: CENT).
tipranks
Frank Palantoni

Frank Palantoni
Lexicon Pharmaceuticals (LXRX)
Director

Not Ranked
Frank Palantoni has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
48.95%
48.93%
2.12%
A breakdown of Frank Palantoni's holdings

Insider Roles

Prestige Consumer Healthcare
(PBH)
CEO & President, Director
Central Garden Pet
(CENT)
EVP
Lexicon Pharmaceuticals
(LXRX)
Director
Roles that Frank Palantoni holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Frank Palantoni

Frank Palantoni's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lexicon Pharmaceuticals
May 22, 2023
Director
Uninformative Buy
$104.86K
Prestige Consumer Healthcare
CEO & President, Director
$2.42M
Central Garden Pet
Feb 15, 2012
EVP
Uninformative Buy
$2.42M
List of latest transactions for each holding click on a transaction to see Frank Palantoni's performance on stock

Frank Palantoni insider profile FAQ

What is the percentage of profitable transactions made by Frank Palantoni?
The percentage of profitable transactions made by Frank Palantoni is ―.
    What is the average return per transaction made by Frank Palantoni?
    The average return per transaction made by Frank Palantoni is ―.
      What stocks does Frank Palantoni hold?
      Frank Palantoni holds: LXRX, PBH, CENT stocks.
        What was Frank Palantoni’s latest transaction?
        Frank Palantoni latest transaction was an Uninformative Buy of ―.
          What was Frank Palantoni's most profitable transaction?
          Frank Palantoni’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Frank Palantoni's role in Lexicon Pharmaceuticals?
            Frank Palantoni's role in Lexicon Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.